IGF1 and Miyoshi myopathy: In vivo and in vitro, IGF-1 decreases drug sensitivity of MM cells, and upregulates a series of anti-apoptotic proteins such as A1/Bfl-1, XIAP and Bcl-2 [10], [11], [12].